Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -555.2% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 60.7 | n/a |
Pr/Book | 3.8 |
Latest | F'cast | |
---|---|---|
Revenue | -31.8% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 1.70 | (3.51) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.16 | (6.95) | (27.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
BUSINESS UPDATE | 19-Jan-2023 | 07:00 | RNS |
ARECOR ANNOUNCES TRANSFER OF AT307 TO HIKMA | 12-Jan-2023 | 07:00 | RNS |
Grant of LTIP Options and PDMR Dealing | 06-Dec-2022 | 16:03 | RNS |
Arecor ends 2022 in line with forecasts | 19-Jan-2023 | ShareCast |
Arecor's Tetris launches 'Ogluo' in Austria | 04-Jan-2023 | ShareCast |
Arecor inks formulation study deal with 'leading... | 10-Nov-2022 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 230.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 420.00 |
52 Week Low | 210.00 |
Volume | 0 |
Shares Issued | 30.62m |
Market Cap | £70.42m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
CEO | Sarah Jennifer Howell |
CFO | Susan Lowther |
You are here: research